Use of a Visual Pedagogy and Structure With Children With Autism for Routine Physical Exams
NCT ID: NCT03232775
Last Updated: 2017-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2007-09-30
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)
NCT03015272
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
NCT03002363
Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning
NCT06332144
Investigating Phenotypic Profiles of Children and Adolescents With ASD
NCT02700113
Tool for Evaluating the Effectiveness of the DENVER Protocol
NCT06253793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design, setting, patients, intervention: Fifteen study participants, aged 5-10 years, with autism and identified by caregivers as typically uncooperative with physical exams were randomized to one of two physical exam groups (treatment and control) based on their adaptive communication score. The treatment group exam included use of a picture schedule-reinforcement book and the control group exam did not introduce the book. Caregivers rated participants' irritability/stereotypy behaviors before and during study exams. Exam teams blinded to study aims, recorded participants' total exam items completed and caregivers rated participants' level of cooperation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Treatment: Physical Exam with Visual Pedagogy and Structure
Treatment: Physical Exam with Visual Pedagogy and Structure
Routine physical examination participants receive visual pedagogy and reinforcement (preferred food treat).
Control
Control: Physical Exam without Visual Pedagogy and Structure
Control: Physical Exam without Visual Pedagogy and Structure
Participants engage in routine physical examination without visual pedagogy and reinforcement (preferred food treat).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment: Physical Exam with Visual Pedagogy and Structure
Routine physical examination participants receive visual pedagogy and reinforcement (preferred food treat).
Control: Physical Exam without Visual Pedagogy and Structure
Participants engage in routine physical examination without visual pedagogy and reinforcement (preferred food treat).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Presumptive diagnosis of Autistic Disorder or Asperger's Disorder prior to study admission from a psychologist or psychiatrist experienced with children who have autism.
3. Meets research criteria for Autistic Spectrum Disorder:
1. Meets cut-off scores for autism spectrum on the Social Communication Questionnaire (SCQ) (cut-off = 15) and
2. Meets empirically-derived algorithm cut-off scores for Autism Spectrum Disorders on the Autism Diagnostic Observation Schedule (ADOS).
3. All subjects will have the ADOS administered by a clinician trained in research reliability standards.
4. The Principal Investigator, a certified ADOS trainer and research reliable, or trained designee under the supervision of the Principal Investigator, will administer the ADOS.
4. Participants will represent the typical DSM-IV diagnostic developmental profile of children on the autism spectrum and no neurological injuries or illnesses before the age of three years that could account for their symptoms (i.e., meningitis, encephalitis, severe head injury or seizure disorder).
5. A Communication standard score ≤ 85, as measured by the Vineland Adaptive Behavior Scales - II.
a) The VABS-II will be administered by the Principal Investigator or trained designee under the supervision of the Principal Investigator as part of the initial phone screening process.
6. Children with an ASD, particularly school-aged children and adolescents, may present with myriad prescribed psychotropic medications. Therefore, we will not exclude children on a variety of psychotropic medications; rather we will conduct a qualitative analysis to look at this issue.
7. No restrictions regarding race or gender will be applied to the autism or developmental disability sample. Every effort will be made not to over-represent any particular race and/or gender group.
8. Physically healthy prior to physical exam.
9. Previous exposure to visual systems. This will be assessed based on caregiver report during the phone screening using one question relating to the use of visual structure with the child.
10. History of:
1. Poor Cooperation
2. Completely Uncooperative
3. Physical exams rated by caregiver on 4-point scale of cooperation modified from Forsberg et al. \[56\].
* 0 = No problems with cooperation;
* 1 = Minor problems with cooperation: Child shows mild behavior problems and/or anxiety symptoms;
* 2 = Poor cooperation: Child's behavior problems and/or anxiety symptoms requires that the medical staff have to spend extra time and effort to manage the child and complete the exam;
* 3 = Completely uncooperative: Exam is not possible due to child's behavior problems and/or anxiety symptoms
Exclusion Criteria
2. Presence of the following genetic or progressive neurological disorders known to be causative of or potentially resulting in a phenotype similar to autism:
1. Fragile X,
2. Landau Kleffner, Rett Disorder,
3. Childhood Disintegrative Disorder, or
4. Tuberous Sclerosis, based on screening by clinical staff and subsequent review by medical staff as needed
3. Presence of vision or hearing loss or significant motor impairments.
4. Wards of the State.
4 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Colorado
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robin Gabriels, PsyD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-0362
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.